Kukje Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Kukje Pharma has a total shareholder equity of ₩84.9B and total debt of ₩30.0B, which brings its debt-to-equity ratio to 35.3%. Its total assets and total liabilities are ₩163.3B and ₩78.3B respectively.
Key information
35.3%
Debt to equity ratio
₩30.00b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩10.63b |
| Equity | ₩84.95b |
| Total liabilities | ₩78.31b |
| Total assets | ₩163.26b |
Recent financial health updates
Recent updates
Kukje Pharma Co., Ltd.'s (KRX:002720) Share Price Not Quite Adding Up
Mar 20
Kukje Pharma's (KRX:002720) Solid Profits Have Weak Fundamentals
Mar 20If You Had Bought Kukje Pharma (KRX:002720) Stock A Year Ago, You Could Pocket A 121% Gain Today
Mar 19These 4 Measures Indicate That Kukje Pharma (KRX:002720) Is Using Debt Reasonably Well
Feb 21What Type Of Shareholders Own The Most Number of Kukje Pharma Co., Ltd. (KRX:002720) Shares?
Jan 25
Kukje Pharma Co., Ltd.'s (KRX:002720) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 30Investors Who Bought Kukje Pharma (KRX:002720) Shares Five Years Ago Are Now Up 227%
Dec 04Financial Position Analysis
Short Term Liabilities: A002720's short term assets (₩55.1B) do not cover its short term liabilities (₩59.7B).
Long Term Liabilities: A002720's short term assets (₩55.1B) exceed its long term liabilities (₩18.6B).
Debt to Equity History and Analysis
Debt Level: A002720's net debt to equity ratio (22.8%) is considered satisfactory.
Reducing Debt: A002720's debt to equity ratio has reduced from 42.2% to 35.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A002720 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A002720 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 7.4% per year.